Mai Capital Management Novartis Ag Transaction History

Mai Capital Management

$13.2 Billion
Q4 2024

A detailed history of Mai Capital Management transactions in Novartis Ag stock. As of the latest transaction made, Mai Capital Management holds 24,061 shares of NVS stock, worth $2.67 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

24,061

Previous 17,589 36.8%

Holding current value

$2.67 Million

Previous $2.02 Million 15.72%

% of portfolio

0.02%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$96.78 - $117.18 $626,360 - $758,388	6,472 Added 36.8%	24,061 $2.34 Million
Q3 2024 Nov 07, 2024	SELL	$106.13 - $120.89 $2.03 Million - $2.32 Million	-19,168 Reduced 52.15%	17,589 $2.02 Million
Q2 2024 Aug 12, 2024	BUY	$92.57 - $107.37 $357,968 - $415,199	3,867 Added 11.76%	36,757 $3.91 Million
Q1 2024 May 08, 2024	BUY	$95.27 - $108.47 $707,475 - $805,498	7,426 Added 29.16%	32,890 $3.18 Million
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $189,430 - $208,461	2,053 Added 8.77%	25,464 $2.57 Million
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $25,198 - $27,964	-266 Reduced 1.12%	23,411 $2.38 Million
Q2 2023 Aug 02, 2023	BUY	$92.52 - $104.91 $750,707 - $851,239	8,114 Added 52.14%	23,677 $2.39 Million
Q1 2023 May 10, 2023	BUY	$80.03 - $92.81 $35,613 - $41,300	445 Added 2.94%	15,563 $1.43 Million
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $252,941 - $309,756	3,348 Added 28.45%	15,118 $1.37 Million
Q3 2022 Nov 15, 2022	BUY	$74.61 - $87.26 $260,165 - $304,275	3,487 Added 42.1%	11,770 $895,000
Q2 2022 Jul 19, 2022	BUY	$80.52 - $93.75 $60,792 - $70,781	755 Added 10.03%	8,283 $700,000
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $81,952 - $92,704	1,023 Added 15.73%	7,528 $661,000
Q4 2021 Feb 11, 2022	SELL	$79.7 - $88.13 $620,703 - $686,356	-7,788 Reduced 54.49%	6,505 $569,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $9,241 - $10,750	113 Added 0.8%	14,293 $1.17 Million
Q2 2021 Jul 19, 2021	BUY	$85.24 - $94.15 $46,370 - $51,217	544 Added 3.99%	14,180 $1.29 Million
Q1 2021 May 10, 2021	BUY	$83.5 - $98.47 $142,952 - $168,580	1,712 Added 14.36%	13,636 $1.17 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $25,060 - $30,312	321 Added 2.77%	11,924 $1.13 Million
Q3 2020 Oct 26, 2020	SELL	$82.14 - $91.0 $53,144 - $58,877	-647 Reduced 5.28%	11,603 $1.01 Million
Q2 2020 Jul 27, 2020	SELL	$80.93 - $91.1 $31,805 - $35,802	-393 Reduced 3.11%	12,250 $1.07 Million
Q1 2020 Apr 16, 2020	BUY	$70.67 - $99.01 $3,745 - $5,247	53 Added 0.42%	12,643 $1.04 Million
Q4 2019 Feb 03, 2020	BUY	$84.35 - $95.37 $729,037 - $824,282	8,643 Added 218.98%	12,590 $1.19 Million
Q3 2019 Oct 29, 2019	SELL	$85.54 - $94.26 $94,607 - $104,251	-1,106 Reduced 21.89%	3,947 $343,000
Q2 2019 Aug 15, 2019	SELL	$75.4 - $92.8 $10,706 - $13,177	-142 Reduced 2.73%	5,053 $461,000
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $22,897 - $26,189	-304 Reduced 5.53%	5,195 $499,000
Q4 2018 Jan 30, 2019	BUY	$73.66 - $82.02 $405,056 - $451,027	5,499 New	5,499 $472,000

Others Institutions Holding NVS

# of Institutions

1,493

Shares Held

131M

Call Options Held

1.31M

Put Options Held

1.56M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.

Account

Mai Capital Management Novartis Ag Transaction History